Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

118.65
Delayed Data
As of Jan 19
 -3.64 / -2.98%
Today’s Change
35.83
Today|||52-Week Range
137.88
+6.17%
Year-to-Date
4 Best Marijuana Stocks to Play the Green Rush
Jan 19 / Zacks.com - Paid Partner Content
Can You Get Rich Off Marijuana Stocks?
Jan 17 / Zacks.com - Paid Partner Content
GW Pharmaceuticals' Biggest Win in 2016
Jan 19 / MotleyFool.com - Paid Partner Content
5 Healthcare Stocks Poised for Maximum Gains in 2017
Jan 17 / MotleyFool.com - Paid Partner Content
Zacks Market Edge Highlights: GW Pharmaceuticals and Scotts Miracle Gro
Jan 19 / Zacks.com - Paid Partner Content
Top Stocks to Buy in 2017
Jan 07 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close122.29
Today’s open122.73
Day’s range118.41 - 123.34
Volume381,086
Average volume (3 months)558,977
Market cap$3.0B
Dividend yield--
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)-19.04%
Earnings growth (this year)-86.40%
Earnings growth (next 5 years)-50.35%
Revenue growth (last year)-66.86%
P/E ratio--
Price/Sales205.08
Price/Book5.77

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-2.35-3.44%
CBPOChina Biologic Produ...-0.52-0.48%
ENDPEndo International P...-0.27-2.05%
RAREUltragenyx Pharmaceu...-0.89-1.26%
Data as of 01/19/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$1.45
Annual revenue (last year)$14.6M
Annual profit (last year)-$90.0M
Net profit margin-617.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts


Search for Jobs